WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
about
Endothelial perturbations and therapeutic strategies in normal tissue radiation damageA mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced deathThe E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cellsRadioprotective effect of American ginseng on human lymphocytes at 90 minutes postirradiation: a study of 40 casesLow-dose cancer risk modeling must recognize up-regulation of protection.SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells.Radioprotective potential of histamine on rat small intestine and uterus.PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells.Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells.Combating radiation therapy-induced damage to the ovarian environmentHistamine protects bone marrow against cellular damage induced by ionising radiation.Sesamol ameliorates radiation induced DNA damage in hematopoietic system of whole body γ-irradiated mice.Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation.Ferulic acid protects lymphocytes from radiation-predisposed oxidative stress through extracellular regulated kinase.Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine.
P2860
Q27027572-424D282D-1AD2-4323-9D7C-5550DD6A2438Q28393741-EEC6802D-F920-4F6A-A01E-B4975BDAD1AAQ30268527-559D2A14-8150-42D2-B7D6-F5DBDCDA527AQ33702175-1095D250-0B07-4F6A-A77E-836719B53DE0Q33876342-81E96484-22D7-4225-AE44-B755A23B0A13Q33929150-B3251175-CFA4-417D-85A6-9B49D0D918A3Q34768277-90458276-5442-44FC-8B73-F6BD90240857Q36596572-DE7AC04E-EFE2-42EA-AEA4-1A806CDEA4F4Q37706714-6C182D68-B475-4707-94A6-9D92A31824DBQ38738226-5EFFE36B-F5CB-4691-93D7-629ADBE1B18FQ38818330-7A701D87-FEAD-4528-A06F-3CAD1BCDB277Q43114746-1A72C979-032D-4AA8-A4F1-1915503D126DQ51832847-F0DF8D54-AD03-4891-BE1F-21B6A3E27E79Q53284736-FD1295C6-3A24-4846-BB15-C10A5A360F0DQ54636169-D0D57A77-7C14-4E07-B3C1-A1C9CB761C83Q55410821-FF7C45A3-D41A-40ED-B546-1B6D09167781
P2860
WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
WR-1065, the active metabolite ...... d delayed genomic instability.
@en
WR-1065, the active metabolite ...... d delayed genomic instability.
@nl
type
label
WR-1065, the active metabolite ...... d delayed genomic instability.
@en
WR-1065, the active metabolite ...... d delayed genomic instability.
@nl
prefLabel
WR-1065, the active metabolite ...... d delayed genomic instability.
@en
WR-1065, the active metabolite ...... d delayed genomic instability.
@nl
P2093
P2860
P1476
WR-1065, the active metabolite ...... ed delayed genomic instability
@en
P2093
David J Grdina
Janet E Baulch
Jaroslaw Dziegielewski
Jeffrey S Murley
Wilfried Goetz
William F Morgan
P2860
P304
P356
10.1016/J.FREERADBIOMED.2008.09.004
P577
2008-09-18T00:00:00Z